Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Larsson

Showing results (21-30 of 316) with videos related to

Pageof 32
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1982
End-stage chronic renal failure due to total uterine prolapseL Nässberger, R Larsson
Biochimica Et Biophysica Acta|May 22, 1990
Modulation of vincristine sensitivity of human kidney tumor cells by pharmacological agents interfering with intracellular signals. No apparent relationship to changes in cytoplasmic Ca2+ or pHP Nygren, R Larsson
Lakartidningen|January 23, 1991
[Short stature. The debate concerns us]R Larsson, A Lundell-Couchèr
Haemostasis|July 27, 1999
Adenosine 5'-diphosphate-induced platelet aggregation in uremia shows resistance to inhibition by the novel nitric oxide donor GEA 3175 but not by S-nitroso-N-acetylpenicillamineP A Whiss, R Larsson
The Journal of Chemical Physics|October 22, 2025
Computing excited eigenstates using inexact Lanczos methods and tree tensor network statesMadhumita Rano, Henrik R Larsson
Physical Chemistry Chemical Physics : PCCP|September 16, 2024
2500 vibronic eigenstates of the NO<sub>3</sub> radicalHenrik R Larsson, Alexandra Viel
Carcinogenesis|February 1, 1988
Active oxygen induced DNA strand breakage and poly ADP-ribosylation in promotable and non-promotable JB6 mouse epidermal cellsD Muehlematter, R Larsson, P Cerutti
Biochemical Society Transactions|October 1, 1985
Co-oxidation of xenobioticsP Moldéus, D Ross, R Larsson
Anti-Cancer Drugs|January 1, 1996
Correlation between sensitivity in vitro of patient chronic lymphocytic leukemia cells and clinical systemic exposure at the maximum tolerated dose for cell cycle phase-specific (type 2) anticancer drugsH Fridborg, N Nygren, R Larsson
Biomaterials|December 4, 2004
The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulationM Johnell, R Larsson, A Siegbahn
Pageof 32

Showing results (21-30 of 316) with videos related to

Sort By:
Pageof 32
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1982
End-stage chronic renal failure due to total uterine prolapseL Nässberger, R Larsson
Biochimica Et Biophysica Acta|May 22, 1990
Modulation of vincristine sensitivity of human kidney tumor cells by pharmacological agents interfering with intracellular signals. No apparent relationship to changes in cytoplasmic Ca2+ or pHP Nygren, R Larsson
Lakartidningen|January 23, 1991
[Short stature. The debate concerns us]R Larsson, A Lundell-Couchèr
Haemostasis|July 27, 1999
Adenosine 5'-diphosphate-induced platelet aggregation in uremia shows resistance to inhibition by the novel nitric oxide donor GEA 3175 but not by S-nitroso-N-acetylpenicillamineP A Whiss, R Larsson
The Journal of Chemical Physics|October 22, 2025
Computing excited eigenstates using inexact Lanczos methods and tree tensor network statesMadhumita Rano, Henrik R Larsson
Physical Chemistry Chemical Physics : PCCP|September 16, 2024
2500 vibronic eigenstates of the NO<sub>3</sub> radicalHenrik R Larsson, Alexandra Viel
Carcinogenesis|February 1, 1988
Active oxygen induced DNA strand breakage and poly ADP-ribosylation in promotable and non-promotable JB6 mouse epidermal cellsD Muehlematter, R Larsson, P Cerutti
Biochemical Society Transactions|October 1, 1985
Co-oxidation of xenobioticsP Moldéus, D Ross, R Larsson
Anti-Cancer Drugs|January 1, 1996
Correlation between sensitivity in vitro of patient chronic lymphocytic leukemia cells and clinical systemic exposure at the maximum tolerated dose for cell cycle phase-specific (type 2) anticancer drugsH Fridborg, N Nygren, R Larsson
Biomaterials|December 4, 2004
The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulationM Johnell, R Larsson, A Siegbahn
Pageof 32